secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001213900-22-078742
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larkspur Health Acquisition Corp. stockholders approve ZyVersa merger; 7.7M shares redeemed
--------------------------------------------------------------------------------

- Stockholders approved business combination with ZyVersa Therapeutics: 6,543,525 for, 785,791 against.
- Approved charter amendments, 2022 Omnibus Incentive Plan, and Nasdaq issuance proposals.
- 7,667,029 shares tendered for redemption, ~76% of outstanding shares (10,029,221).
- Special meeting held Dec 8, 2022; 73.08% quorum achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/0001213900-22-078742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000121390022078742/ea169867-8k_larkspur.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-078742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer